If you suffered a leg, foot or toe amputation after using Invokana™, Invokamet®, or Invokamet® XR, you may be entitled to a cash award.
Two recent clinical trials – the CANVAS (Canagliflozin Cardiovascular Assessment Study) and CANVAS-R (A Study of the Effects of Canagliflozin on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus) – revealed that patients taking canagliflozin (Invokana™, Invokamet®, and Invokamet® XR) were almost twice as likely to experience a leg, foot or toe amputation as patients taking a placebo. The most common amputations were of toes and middle of the foot; leg amputations both above and below the knee were also observed. This risk of amputation may be higher for people with peripheral vascular disease, diabetic foot ulcers (sores), neuropathy (nerve damage), and patients who have had an amputation in the past.
How It Works
While some diabetes medications work by making the body more sensitive to insulin or by making the body secrete more insulin, Invokana™ treats diabetes by causing the kidneys to remove sugar from the body through the urine. As a result, blood sugar is lowered and the effects of diabetes are reduced.
Other Side Effects
The increased risk of leg, foot and toe amputation linked to Invokana™ is a new finding. However, several other side effects have been known for some time. These include:
• Cardiovascular Problems
• Kidney Damage
• Heart Attack
If you or a loved one have had a leg, foot or toe amputation, suffered kidney damage, a heart attack, or ketoacidosis, you may be entitled to money damages. Call the Gold Shield Group at 877-575-4853.